Walleye Trading’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,900
Closed -$144K 4529
2026
Q1
$144K Sell
19,900
-2,300
-10% -$30K ﹤0.01% 3291
2025
Q4
$377K Buy
22,200
+21,700
+4,340% +$220K ﹤0.01% 3004
2025
Q3
$3.66K Buy
+500
New +$4.04K ﹤0.01% 4258
2022
Q1
Sell
-200
Closed -$1K 5974
2021
Q4
$1K Buy
+200
New +$830 ﹤0.01% 5266
2021
Q1
Sell
-18,700
Closed -$147K 5376
2020
Q4
$147K Buy
+18,700
New +$157K ﹤0.01% 3717
2020
Q2
Sell
-100
Closed -$1K 4661
2020
Q1
$1K Buy
+100
New +$852 ﹤0.01% 3873
2019
Q3
Sell
-3,000
Closed -$78K 4493
2019
Q2
$78K Buy
+3,000
New +$84.1K ﹤0.01% 3399

Other funds holding WVE

Walleye Trading's WVE Position: Q2 2026 in Review

Walleye Trading sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 16,288 shares — an estimated $118K sold.

Walleye Trading first reported a position in WVE in Q4 2020 and held it in 5 quarters. The position peaked at $565K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Walleye Trading reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 16,288 Wave Life Sciences shares in Q2 2026, an estimated $118K.
  • Walleye Trading first reported a position in Wave Life Sciences in Q4 2020 and held it in 5 quarters.
  • Walleye Trading's Wave Life Sciences position peaked at $565K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.